Matches in SemOpenAlex for { <https://semopenalex.org/work/W3088490108> ?p ?o ?g. }
- W3088490108 endingPage "704" @default.
- W3088490108 startingPage "695" @default.
- W3088490108 abstract "The aims of this pilot study were to evaluate the feasibility and efficacy of high-dose hypofractionated volumetric modulated arc radiotherapy (VMAT) applied to whole pelvic region radiotherapy (WPRT) with multilevel simultaneous integrated boost (MLSIB) combined with piroxicam and chemotherapy for the treatment of canine transitional cell carcinoma (TCC) of the lower urinary tract with muscle invasion TCC. Twelve dogs were enrolled, according to stage, in two groups: group 1, TCC confined to the urinary tract; group 2, TCC with metastasis. The planning target volume dose was tailored from 36 to 42 Gy in 6 fractions. All dogs were prescribed piroxicam and radiosensitizing carboplatin, and six received chemotherapy after radiotherapy. Serial follow-ups with computed tomography and magnetic resonance imaging were performed. Disease control and toxicity effects were evaluated according to the Response Evaluation Criteria in Solid Tumors and Veterinary Radiation Therapy Oncology Group criteria. The treatment was well tolerated, and no high-grade side effects were reported. The median overall survival times for groups 1 and 2 were 1,230 and 150 days, respectively. A considerable percentage of patients in group1 (50%) were still alive at the time of writing this paper, and a longer follow-up could enable a more accurate survival analysis. This preliminary analysis shows that VMAT applied to the WPRT with MLSIB is an effective and safe option for dogs with lower urinary TCC, although the presence of metastases worsens the prognosis." @default.
- W3088490108 created "2020-10-01" @default.
- W3088490108 creator A5014155191 @default.
- W3088490108 creator A5024168577 @default.
- W3088490108 creator A5025431876 @default.
- W3088490108 creator A5032655385 @default.
- W3088490108 creator A5040176149 @default.
- W3088490108 creator A5052773550 @default.
- W3088490108 creator A5055011264 @default.
- W3088490108 creator A5062177968 @default.
- W3088490108 creator A5076717259 @default.
- W3088490108 creator A5086972219 @default.
- W3088490108 date "2021-01-01" @default.
- W3088490108 modified "2023-10-14" @default.
- W3088490108 title "A combined protocol with piroxicam, chemotherapy, and whole pelvic irradiation with simultaneous boost volumetric modulated arc radiotherapy for muscle-invasive canine urinary transitional cell carcinoma: First clinical experience" @default.
- W3088490108 cites W1484135384 @default.
- W3088490108 cites W1527747488 @default.
- W3088490108 cites W1575085038 @default.
- W3088490108 cites W1613601325 @default.
- W3088490108 cites W1963650567 @default.
- W3088490108 cites W1964525391 @default.
- W3088490108 cites W1971028719 @default.
- W3088490108 cites W1986197573 @default.
- W3088490108 cites W1986616957 @default.
- W3088490108 cites W2000191440 @default.
- W3088490108 cites W2006091738 @default.
- W3088490108 cites W2006119682 @default.
- W3088490108 cites W2007326663 @default.
- W3088490108 cites W2008068065 @default.
- W3088490108 cites W2012053260 @default.
- W3088490108 cites W2012692061 @default.
- W3088490108 cites W2016395729 @default.
- W3088490108 cites W2019607817 @default.
- W3088490108 cites W2023003206 @default.
- W3088490108 cites W2026013761 @default.
- W3088490108 cites W2040175765 @default.
- W3088490108 cites W2040774012 @default.
- W3088490108 cites W2041154630 @default.
- W3088490108 cites W2045804335 @default.
- W3088490108 cites W2046265114 @default.
- W3088490108 cites W2047023073 @default.
- W3088490108 cites W2054200094 @default.
- W3088490108 cites W2084562362 @default.
- W3088490108 cites W2087027348 @default.
- W3088490108 cites W2092758402 @default.
- W3088490108 cites W2100838274 @default.
- W3088490108 cites W2114865765 @default.
- W3088490108 cites W2117643013 @default.
- W3088490108 cites W2118127784 @default.
- W3088490108 cites W2120735723 @default.
- W3088490108 cites W2123732584 @default.
- W3088490108 cites W2124866777 @default.
- W3088490108 cites W2136706275 @default.
- W3088490108 cites W2138609461 @default.
- W3088490108 cites W2141289846 @default.
- W3088490108 cites W2145475510 @default.
- W3088490108 cites W2148968400 @default.
- W3088490108 cites W2150129618 @default.
- W3088490108 cites W2157553455 @default.
- W3088490108 cites W2195248692 @default.
- W3088490108 cites W2314845882 @default.
- W3088490108 cites W2345148289 @default.
- W3088490108 cites W2345157270 @default.
- W3088490108 cites W2415875989 @default.
- W3088490108 cites W2417842359 @default.
- W3088490108 cites W2535591407 @default.
- W3088490108 cites W2541427119 @default.
- W3088490108 cites W2549273821 @default.
- W3088490108 cites W2554478478 @default.
- W3088490108 cites W2576972117 @default.
- W3088490108 cites W2590369803 @default.
- W3088490108 cites W2791877723 @default.
- W3088490108 cites W2896730825 @default.
- W3088490108 cites W2924910315 @default.
- W3088490108 cites W2940999692 @default.
- W3088490108 cites W2969856517 @default.
- W3088490108 cites W2980124657 @default.
- W3088490108 cites W4238766923 @default.
- W3088490108 cites W4251638272 @default.
- W3088490108 cites W4293241248 @default.
- W3088490108 doi "https://doi.org/10.1292/jvms.19-0662" @default.
- W3088490108 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8111339" @default.
- W3088490108 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32963177" @default.
- W3088490108 hasPublicationYear "2021" @default.
- W3088490108 type Work @default.
- W3088490108 sameAs 3088490108 @default.
- W3088490108 citedByCount "3" @default.
- W3088490108 countsByYear W30884901082021 @default.
- W3088490108 countsByYear W30884901082022 @default.
- W3088490108 countsByYear W30884901082023 @default.
- W3088490108 crossrefType "journal-article" @default.
- W3088490108 hasAuthorship W3088490108A5014155191 @default.
- W3088490108 hasAuthorship W3088490108A5024168577 @default.
- W3088490108 hasAuthorship W3088490108A5025431876 @default.
- W3088490108 hasAuthorship W3088490108A5032655385 @default.
- W3088490108 hasAuthorship W3088490108A5040176149 @default.
- W3088490108 hasAuthorship W3088490108A5052773550 @default.
- W3088490108 hasAuthorship W3088490108A5055011264 @default.